Diuretic therapy in congestive heart failure - New aspects regarding spironolactone therapy;Diuretische therapie bei herzinsuffizienz - Neue gesichtspunkte zur therapie mit spironolacton

Therapeutische Umschau

Volumn 57, Issue 6, 2000, Pages 374-379

  Haller, C ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; LOOP DIURETIC AGENT; SPIRONOLACTONE; VASOPRESSIN RECEPTOR ANTAGONIST;

CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPOKALEMIA; REVIEW; TREATMENT INDICATION;

EID: 0033944218     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.57.6.374     Document Type: Review

References (20)

1. Ghali JK, Cooper R, Ford E. Trends in hospitalization for heart failure in the United States, 1973-1986: evidence for increasing population prevalence. Arch Intern Med 1990; 150: 769-73.
2. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. New Engl J Med 1988; 319: 1065-72 (Part 1); 1127-34 (Part2).
3. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. New Engl J Med 1988; 319: 1065-72 (Part 1); 1127-34 (Part2).
4. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. New Engl J Med 1999; 341: 577-85.
5. Remme WJ, Cleland JGF, Dargie H et al. The treatment of heart failure. The task force of the working group on heart failure of the European Society of Cardiology. Europ Heart J 1997; 18: 736-53.
6. Dormans TP, Gerlag PG, Russel FG, Smits P. Combination diuretic therapy in severe congestive heart failure. Drugs 1998; 55: 165-72.
7. Haller C, Salbach P, Katus H, Kübler W. Refractory oedema in congestive heart failure: a contributory role of loop diuretics? J Internal Med 1995; 237: 211-4.
8. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab and Clin Med 1983; 102: 450-8.
9. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36: 692-9.
10. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients severe congestive heart failure. Circulation 1986; 73: 257-67.
11. Schrier RW, Martin PY. Recent advances in the understanding of water metabolism in heart failure. Adv Exp Med Biol 1998; 449: 415-26.
12. Siscovick DS, Raghunathan TE, Psaty BM et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. New Engl J Med 1994; 330: 1852-7.
13. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991; 325: 293-302.
14. Pitt B. «Escape» of aldosteroneproduction in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs and Therapy 1995; 9: 145-9.
15. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65.
16. Slight SH, Joseph J, Ganjam VK, Weber KT. Extra-adrenal mineralocorticoids and cardiovascular tissue. J Mol Cell Cardiol 1999; 31: 1175-84.
17. Weber KT, Villareal D. Aldosterone and antialdosterone therapy in congestive heart failure. Am J Cardiol 1993; 71: 3A-11A.
18. Weber KT. Aldosterone and spironolactone in heart failure. New Engl J Med 1999; 341: 753-5.
19. The RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The randomized aldactone evaluation study (RALES)). Am J Cardiol 1996; 78: 902-7.
20. Pitt B, Zannad F, Remme Wet al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 1999; 341: 709-17.